PIC – 40% cash back when you register for an Equip Global Conference or Training Course
The objectives of the PIC Scheme are the same as those of Equip Global. Both support investment in innovation, productivity and continuous training.
If you are a registered business in Singapore, you can enjoy huge huge tax savings in the form of cash payouts and/or tax deductions when you invest in training of employees. Your attendance at any Equip Global conference or training course is eligible for PIC credits, either as a 40% cash refund or 400% tax deduction. We will provide you with full supporting documentation after the event and assist you in getting the claim completed.
Continuous training and upgrading of your employees is key to the success of your organization. What’s more, boost your tax savings and claim 40% of your registration fee by attending an Equip Global conference or training course today. To do so, follow this simple 5 minute process:
- Select, register and pay for your conference/training course of your choice
- Complete the PIC form which you can download here:
http://www.iras.gov.sg/irasHome/uploadedFiles/Quick_Links/Tax_forms/Business_and_employers/Cash%20Payout%20Application%20Form_B2011_final.xls
- Attend the event, learn and network with industry peers
- File your receipt (which we will email you), record of attendance (which we will provide you at the event) and the completed PIC form with your accounts department which they will submit to IRAS to process the claim. If you do not have an accounts department or need help with the PIC claim, our staff will be very happy to assist.
Take advantage of the PIC scheme to upgrade your skills, gain the latest information in your field of work, and get access to the knowledge that can help drive your organizations’ performance and productivity.
For more information visit http://www.iras.gov.sg/irashome/picredit.aspx. Terms and conditions apply.
Han Jeong HoonChief Business OfficerEutilex
Roberto NitschAssociate DirectorAstraZeneca
Dr Prateek GuptaVice President and Head, Process Development & MSATStelis Biopharma Ltd
Dr Markus HaindlGlobal Head of Gene Therapy DevelopmentRoche
Dr Gail NaughtonChief Scientific Officer & FounderHistogen
Dr Sandy QlintangDeputy DirectorStem Cell and Cancer Institute KALBE
Dr Seong-Wook LeePresident and CEORznomics Inc.
Dr Jenny PrangeChief Scientific OfficerMUVON Therapeutics
Dr Akhilesh SharmaPresident and Chief Medical OfficerAlkem Laboratories Ltd.
Magali TAIELChief Medical OfficerGenSight Biologics
Dr. Hemant DhamneHead of Gene & Cell Therapy ResearchImmnueel Therapeutics
Dr Shashwati BasakAssociate Vice President Associate Vice President, Head, Cell Therapies and AnalyticalCenter of Cell and Gene Therapy, Intas Pharmaceuticals Ltd. (Biopharma Division)
Dr Sareina WuFounder and Chief Scientific Officer,GenomeFrontier Therapeutics